A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses. (Q39807606)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

Jordi Martínez-Quintanilla

6 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

J J Rojas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Cascallo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

S Guedan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

A Hemminki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

R Alemany

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

1 reference

1 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1441-1451

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19710704%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gt.2009.103

6 February 2020

exact match

0 references

cites work

Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

The RB and p53 pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Regulation of E2F: a family of transcription factors involved in proliferation control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Identification of a cellular transcription factor involved in E1A trans-activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Induction of the cellular E2F-1 promoter by the adenovirus E4-6/7 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Acute hepatotoxicity of oncolytic adenoviruses in mouse models is associated with expression of wild-type E1a and induction of TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Infection of Mouse Liver by Human Adenovirus Type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Oncolytic viral therapies - the clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

The role of adenovirus early region 1A in the regulation of early regions 2A and 1B expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

E1A control of gene expression is mediated by sequences 5' to the transcriptional starts of the early viral genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Control of E1A under an E2F-1 promoter insulated with the myotonic dystrophy locus insulator reduces the toxicity of oncolytic adenovirus Ad-Delta24RGD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

The regulation of E2F by pRB-family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

An adenovirus E4 gene product trans-activates E2 transcription and stimulates stable E2F binding through a direct association with E2F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expression levels has little effect on virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Cancer selective adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Human matrix metalloproteinase-8 gene delivery increases the oncolytic activity of a replicating adenovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

5-Fluorocytosine increases the toxicity of Wnt-targeting replicating adenoviruses that express cytosine deaminase as a late gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Syncytia formation affects the yield and cytotoxicity of an adenovirus expressing a fusogenic glycoprotein at a late stage of replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

Rat liver slices as a tool to study LPS-induced inflammatory response in the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

7 January 2021

CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

7 January 2021

Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

7 January 2021

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.103

7 January 2021